Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Science News

Parkinson’s Foundation researchers and other scientists worldwide make continual advances in understanding Parkinson’s disease (PD) with revolutionary research. We monitor it all in our effort to improving care and advance research toward a cure. Browse our collection here:

FDA Approves DUOPA™ for Treatment of Motor Fluctuations in Advanced Parkinson’s Disease
Monday, January 12, 2015

The Parkinson’s Disease Foundation (PDF) alerts the community that DUOPA™, a gel formulation of the drug carbidopa/levodopa that is delivered directly to the small intestine through a surgically-placed tube, has been approved by the US Food and Drug Administration (FDA) for the treatment of motor fluctuations in advanced Parkinson's disease.  The drug’s manufacturer, AbbVie, Inc., announced the approval today. 

FDA Approves RYTARY™ for Treatment of Parkinson’s Disease
Thursday, January 8, 2015

The Parkinson’s Disease Foundation (PDF) alerts the community that RYTARYTM, an extended release formulation of carbidopa/levodopa, has been approved by the US Food and Drug Administration (FDA) for the treatment of Parkinson's disease. The approval was announced today by the drug’s manufacturer, Impax Pharmaceuticals.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.